14 results on '"Betts, Michael"'
Search Results
2. Sustained Transgene Expression despite T Lymphocyte Responses in a Clinical Trial of rAAV1-AAT Gene Therapy
- Author
-
Brantly, Mark L., Chulay, Jeffrey D., Wang, Lili, Mueller, Christian, Humphries, Margaret, Spencer, L. Terry, Rouhani, Farshid, Conlon, Thomas J., Calcedo, Roberto, Betts, Michael R., Spencer, Carolyn, Byrne, Barry J., Wilson, James M., Flotte, Terence R., and Verma, Inder M.
- Published
- 2009
- Full Text
- View/download PDF
3. High throughput pMHC-I tetramer library production using chaperone-mediated peptide exchange.
- Author
-
Overall, Sarah A., Toor, Jugmohit S., Hao, Stephanie, Yarmarkovich, Mark, Sara M. O'Rourke, Morozov, Giora I., Nguyen, Son, Japp, Alberto Sada, Gonzalez, Nicolas, Moschidi, Danai, Betts, Michael R., Maris, John M., Smibert, Peter, and Sgourakis, Nikolaos G.
- Subjects
BINDING site assay ,PEPTIDES ,EXCHANGE ,T cells ,MOLECULAR chaperones ,IMMUNE response - Abstract
Peptide exchange technologies are essential for the generation of pMHC-multimer libraries used to probe diverse, polyclonal TCR repertoires in various settings. Here, using the molecular chaperone TAPBPR, we develop a robust method for the capture of stable, empty MHC-I molecules comprising murine H2 and human HLA alleles, which can be readily tetramerized and loaded with peptides of choice in a high-throughput manner. Alternatively, catalytic amounts of TAPBPR can be used to exchange placeholder peptides with high affinity peptides of interest. Using the same system, we describe high throughput assays to validate binding of multiple candidate peptides on empty MHC-I/TAPBPR complexes. Combined with tetramer-barcoding via a multi-modal cellular indexing technology, ECCITE-seq, our approach allows a combined analysis of TCR repertoires and other T cell transcription profiles together with their cognate antigen specificities in a single experiment. The new approach allows TCR/pMHC interactions to be interrogated easily at large scale. Peptide-MHC (pMHC) tetramers are important tools for probing T cell repertoire and adaptive immune responses. Here the authors use a molecular chaperone, TAPBPR, to develop a high-throughput, multiplexible platform for pMHC tetramer generation to facilitate simultaneous assessments of T cell repertoire/antigen specificity and transcriptome. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
4. T-bet and Eomes Are Differentially Linked to the Exhausted Phenotype of CD8+ T Cells in HIV Infection.
- Author
-
Buggert, Marcus, Tauriainen, Johanna, Yamamoto, Takuya, Frederiksen, Juliet, Ivarsson, Martin A., Michaëlsson, Jakob, Lund, Ole, Hejdeman, Bo, Jansson, Marianne, Sönnerborg, Anders, Koup, Richard A., Betts, Michael R., and Karlsson, Annika C.
- Subjects
HIV infections ,CD8 antigen ,T cell differentiation ,LABORATORY mice ,ANTIRETROVIRAL agents - Abstract
CD8+ T cell exhaustion represents a major hallmark of chronic HIV infection. Two key transcription factors governing CD8+ T cell differentiation, T-bet and Eomesodermin (Eomes), have previously been shown in mice to differentially regulate T cell exhaustion in part through direct modulation of PD-1. Here, we examined the relationship between these transcription factors and the expression of several inhibitory receptors (PD-1, CD160, and 2B4), functional characteristics and memory differentiation of CD8+ T cells in chronic and treated HIV infection. The expression of PD-1, CD160, and 2B4 on total CD8+ T cells was elevated in chronically infected individuals and highly associated with a T-bet
dim Eomeshi expressional profile. Interestingly, both resting and activated HIV-specific CD8+ T cells in chronic infection were almost exclusively T-betdim Eomeshi cells, while CMV-specific CD8+ T cells displayed a balanced expression pattern of T-bet and Eomes. The T-betdim Eomeshi virus-specific CD8+ T cells did not show features of terminal differentiation, but rather a transitional memory phenotype with poor polyfunctional (effector) characteristics. The transitional and exhausted phenotype of HIV-specific CD8+ T cells was longitudinally related to persistent Eomes expression after antiretroviral therapy (ART) initiation. Strikingly, these characteristics remained stable up to 10 years after ART initiation. This study supports the concept that poor human viral-specific CD8+ T cell functionality is due to an inverse expression balance between T-bet and Eomes, which is not reversed despite long-term viral control through ART. These results aid to explain the inability of HIV-specific CD8+ T cells to control the viral replication post-ART cessation. [ABSTRACT FROM AUTHOR]- Published
- 2014
- Full Text
- View/download PDF
5. Parasite Fate and Involvement of Infected Cells in the Induction of CD4+ and CD8+ T Cell Responses to Toxoplasma gondii.
- Author
-
Dupont, Christopher D., Christian, David A., Selleck, Elizabeth M., Pepper, Marion, Leney-Greene, Michael, Harms Pritchard, Gretchen, Koshy, Anita A., Wagage, Sagie, Reuter, Morgan A., Sibley, L. David, Betts, Michael R., and Hunter, Christopher A.
- Subjects
TOXOPLASMA gondii ,T cells ,PHAGOCYTES ,PHAGOCYTOSIS ,DENDRITIC cells - Abstract
During infection with the intracellular parasite Toxoplasma gondii, the presentation of parasite-derived antigens to CD4
+ and CD8+ T cells is essential for long-term resistance to this pathogen. Fundamental questions remain regarding the roles of phagocytosis and active invasion in the events that lead to the processing and presentation of parasite antigens. To understand the most proximal events in this process, an attenuated non-replicating strain of T. gondii (the cpsII strain) was combined with a cytometry-based approach to distinguish active invasion from phagocytic uptake. In vivo studies revealed that T. gondii disproportionately infected dendritic cells and macrophages, and that infected dendritic cells and macrophages displayed an activated phenotype characterized by enhanced levels of CD86 compared to cells that had phagocytosed the parasite, thus suggesting a role for these cells in priming naïve T cells. Indeed, dendritic cells were required for optimal CD4+ and CD8+ T cell responses, and the phagocytosis of heat-killed or invasion-blocked parasites was not sufficient to induce T cell responses. Rather, the selective transfer of cpsII-infected dendritic cells or macrophages (but not those that had phagocytosed the parasite) to naïve mice potently induced CD4+ and CD8+ T cell responses, and conferred protection against challenge with virulent T. gondii. Collectively, these results point toward a critical role for actively infected host cells in initiating T. gondii-specific CD4+ and CD8+ T cell responses. [ABSTRACT FROM AUTHOR]- Published
- 2014
- Full Text
- View/download PDF
6. Sustained transgene expression despite I lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy.
- Author
-
Brantly, Mark L., Chulay, Jeffrey D., Lili Wang, Mueller, Christian, Humphries, Margaret, Spencer, L. Terry, Rouhani, Farshid, Conlon, Thomas J., Calcedo, Roberto, Betts, Michael R., Spencer, Carolyn, Byrn, Barry J., Wilson, James M., and Flotte, Terence R.
- Subjects
ALPHA 1-antitrypsin ,IMMUNE response ,TRANSGENE expression ,GENE therapy ,GENETIC transformation ,ENZYME-linked immunosorbent assay ,INTRAMUSCULAR injections - Abstract
Alpha-i antitrypsin (AAT) deficiency is well-suited as a target for human gene transfer. We performed a phase 1, open-label, doseescalation clinical trial of a recombinant adeno-associated virus (rAAV) vector expressing normal (M) AAT packaged into serotype 1 AAV capsids delivered by i.m. injection. Nine AAT-deficient subjects were enrolled sequentially in cohorts of 3 each at doses of 6.9 × 10
12 , 2.2 × 1013 , and 6.0 × 1013 vector genome particles per patient. Four subjects receiving AAT protein augmentation discontinued therapy 28 or 56 days before vector administration. Vector administration was well tolerated, with only mild local reactions and 1 unrelated serious adverse event (bacterial epididymitis). There were no changes in hematology or clinical chemistry parameters. M-specific AAT was expressed above background in all subjects in cohorts 2 and 3 and was sustained at levels 0.1% of normal for at least 1 year in the highest dosage level cohort, despite development of neutralizing antibody and IFN-γ enzyme-linked immunospot responses to AAV1 capsid at day 14 in all subjects. These findings suggest that immune responses to AAV capsid that develop after i.m. injection of a serotype 1 rAAV vector expressing AAT do not completely eliminate transduced cells in this context. [ABSTRACT FROM AUTHOR]- Published
- 2009
- Full Text
- View/download PDF
7. HIV-Specific T-Cells Accumulate in the Liver in HCV/HIV Co-Infection.
- Author
-
Vali, Bahareh, Feng Yun Yue, Jones, R. Brad, Sheth, Prameet M., Kaul, Rupert, Betts, Michael R., Wong, David, Kovacs, Colin, Loutfy, Mona, Common, Andrew, Halpenny, Roberta, and Ostrowski, Mario A.
- Subjects
HEPATITIS C virus ,HIV infections ,LIVER disease diagnosis ,IMMUNOLOGIC diseases ,T-cell lymphoma ,T-cell receptor genes ,IMMUNE adherence reaction ,CYTOKINESIS ,IMMUNE response ,DIAGNOSIS - Abstract
Background and Aims: Hepatitis C Virus (HCV)-related liver disease progresses more rapidly in individuals co-infected with Human Immunodeficiency Virus-1 (HIV), although the underlying immunologic mechanisms are unknown. We examined whether HIV-specific T-cells are identified in the liver of HCV/HIV co-infected individuals and promote liver inflammation through bystander immune responses. Methods: Ex-vivo intra-hepatic lymphocytes from HCV mono-infected and HCV/HIV co-infected individuals were assessed for immune responses to HIV and HCV antigens by polychromatic flow cytometry. Results: HCV/HIV liver biopsies had similar frequencies of lymphocytes but lower percentages of CD4
+ T-cells compared to HCV biopsies. In co-infection, intra-hepatic HIV-specific CD8+ and CD4+ T-cells producing IFN-γ and TNF-α were detected and were comparable in frequency to those that were HCV-specific. In co-infected individuals, viral-specific CD8+ T-cells produced more of the fibrogenic cytokine, TNF-α. In both mono- and co-infected individuals, intra-hepatic HCV-specific T-cells were poorly functional compared to HIV-specific T-cells. In co-infection, HAART was not associated with a reconstitution of intra-hepatic CD4+ T-cells and was associated with reduction in both HIV and HCV-specific intra-hepatic cytokine responses. Conclusion: The accumulation of functional HIV-specific T-cells in the liver during HCV/HIV co-infection may represent a bystander role for HIV in inducing faster progression of liver disease. [ABSTRACT FROM AUTHOR]- Published
- 2008
- Full Text
- View/download PDF
8. Perforin Expression Directly Ex Vivo by HIV-Specific CD8+ T-Cells Is a Correlate of HIV Elite Control
- Author
-
Hersperger, Adam R., Nason, Martha, Demers, Korey, Sheth, Prameet, Shin, Lucy Y., Kovacs, Colin M., Rodriguez, Benigno, Sieg, Scott F., Teixeira-Johnson, Leia, Gudonis, Debbie, Goepfert, Paul A., Lederman, Michael M., Makedonas, George, Kaul, Rupert, Betts, Michael R., Pereyra, Florencia M., Frank, Ian, and Walker, Bruce David
- Subjects
immunology ,immune response ,immunity to infections ,infectious diseases ,HIV infection and AIDS - Abstract
Many immune correlates of CD8+ T-cell-mediated control of HIV replication, including polyfunctionality, proliferative ability, and inhibitory receptor expression, have been discovered. However, no functional correlates using ex vivo cells have been identified with the known ability to cause the direct elimination of HIV-infected cells. We have recently discovered the ability of human CD8+ T-cells to rapidly upregulate perforin—an essential molecule for cell-mediated cytotoxicity—following antigen-specific stimulation. Here, we examined perforin expression capability in a large cross-sectional cohort of chronically HIV-infected individuals with varying levels of viral load: elite controllers (n = 35), viremic controllers (n = 29), chronic progressors (n = 27), and viremic nonprogressors (n = 6). Using polychromatic flow cytometry and standard intracellular cytokine staining assays, we measured perforin upregulation, cytokine production, and degranulation following stimulation with overlapping peptide pools encompassing all proteins of HIV. We observed that HIV-specific CD8+ T-cells from elite controllers consistently display an enhanced ability to express perforin directly ex vivo compared to all other groups. This ability is not restricted to protective HLA-B haplotypes, does not require proliferation or the addition of exogenous factors, is not restored by HAART, and primarily originates from effector CD8+ T-cells with otherwise limited functional capability. Notably, we found an inverse relationship between HIV-specific perforin expression and viral load. Thus, the capability of HIV-specific CD8+ T-cells to rapidly express perforin defines a novel correlate of control in HIV infection.
- Published
- 2010
- Full Text
- View/download PDF
9. Cytokine production and dysregulation in HIV pathogenesis: Lessons for development of therapeutics and vaccines
- Author
-
Reuter, Morgan A., Pombo, Carolina, and Betts, Michael R.
- Subjects
- *
CYTOKINES , *HIV infections , *THERAPEUTICS , *DRUG development , *VIRAL vaccines , *IMMUNE response ,PREVENTION of disease progression - Abstract
Abstract: Numerous studies have characterized the cytokine modulation observed in human immunodeficiency virus (HIV) infected individuals, from initial infection through chronic disease. Progressive and non-progressive HIV infection models show the cytokine milieu differs in terms of production and responsiveness in these two groups, suggesting an understanding of the role cytokines play during infection is necessary for directing the immune response toward viral control. This review will cover cytokine induction and dysfunction during HIV pathogenesis, with a focus on the interplay between cytokines and transcription factors, T cell activation, and exhaustion. We highlight cytokines that have either vaccine adjuvant or therapeutic potential and discuss the need to identify key factors required for prevention of progression, clearance of infection, or protection from acquisition. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
10. Flow cytometric analysis of vaccine responses: how many colors are enough?
- Author
-
Roederer, Mario, Brenchley, Jason M., Betts, Michael R., and De Rosa, Stephen C.
- Subjects
- *
FLOW cytometry , *VACCINES , *T cells , *IMMUNE response - Abstract
The past 5 years have seen an explosion in technological advances related to measuring immunogenicity. Specifically, two distinct areas of development have led to considerably more detailed analysis of T cell responses: first, the ability to measure over a dozen distinct antigens expressed by individual cells simultaneously (12-color flow cytometry); and second, a host of assays that rapidly and viably identify antigen-specific T cells. Together, these technologies reveal the complex heterogeneity of an immune response generated during infection or after vaccine challenge. The next 5 years will see the determination of which underlying variables will be most important to quantifying vaccine efficacy. In this manuscript, we discuss these technologies, with a focus on assisting in the design and implementation of immunogenicity trials for future vaccine efforts. [Copyright &y& Elsevier]
- Published
- 2004
- Full Text
- View/download PDF
11. Derivation and Characterization of a CD4-Independent, Non-CD4- Tropic Simian Immunodeficiency Virus.
- Author
-
Swanstrom, Adrienne E., Haggarty, Beth, Jordan, Andrea P. O., Romanog, Josephine, Leslie, George J., Aye, Pyone P., Marx, Preston A., Lackner, Andrew A., Del Prete, Gregory Q., Robinson, James E., Betts, Michael R., Montefiori, David C., LaBranche, Celia C., and Hoxie, James A.
- Subjects
- *
SIMIAN immunodeficiency virus , *CD4 antigen , *IMMUNE response , *LENTIVIRUSES , *CELL fusion , *HIV - Abstract
CD4 tropism is conserved among all primate lentiviruses and likely contributes to viral pathogenesis by targeting cells that are critical for adaptive antiviral immune responses. Although CD4-independent variants of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) have been described that can utilize the coreceptor CCR5 or CXCR4 in the absence of CD4, these viruses typically retain their CD4 binding sites and still can interact with CD4. We describe the derivation of a novel CD4-independent variant of pathogenic SIVmac239, termed iMac239, that was used to derive an infectious R5-tropic SIV lacking a CD4 binding site. Of the seven mutations that differentiate iMac239 from wild-type SIVmac239, a single change (D178G) in the V1/V2 region was sufficient to confer CD4 independence in cell-cell fusion assays, although other mutations were required for replication competence. Like other CD4-independent viruses, iMac239 was highly neutralization sensitive, although mutations were identified that could confer CD4-independent infection without increasing its neutralization sensitivity. Strikingly, iMac239 retained the ability to replicate in cell lines and primary cells even when its CD4 binding site had been ablated by deletion of a highly conserved aspartic acid at position 385, which, for HIV-1, plays a critical role in CD4 binding. iMac239, with and without the D385 deletion, exhibited an expanded host range in primary rhesus peripheral blood mononuclear cells that included CCR5+ CD8+ T cells. As the first non-CD4-tropic SIV, iMac239-ΔD385 will afford the opportunity to directly assess the in vivo role of CD4 targeting on pathogenesis and host immune responses. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
12. Parasite Fate and Involvement of Infected Cells in the Induction of CD4+ and CD8+ T Cell Responses to Toxoplasma gondii.
- Author
-
Dupont, Christopher D., Christian, David A., Selleck, Elizabeth M., Pepper, Marion, Leney-Greene, Michael, Harms Pritchard, Gretchen, Koshy, Anita A., Wagage, Sagie, Reuter, Morgan A., Sibley, L. David, Betts, Michael R., and Hunter, Christopher A.
- Subjects
- *
TOXOPLASMA gondii , *T cells , *PHAGOCYTES , *PHAGOCYTOSIS , *DENDRITIC cells - Abstract
During infection with the intracellular parasite Toxoplasma gondii, the presentation of parasite-derived antigens to CD4+ and CD8+ T cells is essential for long-term resistance to this pathogen. Fundamental questions remain regarding the roles of phagocytosis and active invasion in the events that lead to the processing and presentation of parasite antigens. To understand the most proximal events in this process, an attenuated non-replicating strain of T. gondii (the cpsII strain) was combined with a cytometry-based approach to distinguish active invasion from phagocytic uptake. In vivo studies revealed that T. gondii disproportionately infected dendritic cells and macrophages, and that infected dendritic cells and macrophages displayed an activated phenotype characterized by enhanced levels of CD86 compared to cells that had phagocytosed the parasite, thus suggesting a role for these cells in priming naïve T cells. Indeed, dendritic cells were required for optimal CD4+ and CD8+ T cell responses, and the phagocytosis of heat-killed or invasion-blocked parasites was not sufficient to induce T cell responses. Rather, the selective transfer of cpsII-infected dendritic cells or macrophages (but not those that had phagocytosed the parasite) to naïve mice potently induced CD4+ and CD8+ T cell responses, and conferred protection against challenge with virulent T. gondii. Collectively, these results point toward a critical role for actively infected host cells in initiating T. gondii-specific CD4+ and CD8+ T cell responses. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
13. CD40L expression permits CD8+ T cells to execute immunologic helper functions.
- Author
-
Frentsch, Marco, Stark, Regina, Matzmohr, Nadine, Meier, Sarah, Durlanik, Sibel, Schulz, Axel R., Stervbo, Ulrik, Jürchott, Karsten, Gebhardt, Friedemann, Heine, Guido, Reuter, Morgan A., Betts, Michael R., Busch, Dirk, and Thiel, Andreas
- Subjects
- *
T cells , *INTRACELLULAR pathogens , *IMMUNOGENETICS , *CELL-mediated cytotoxicity , *IMMUNE response , *GENETICS - Abstract
CD8+ T cells play an essential role in immunity against intracellular pathogens, with cytotoxicity being considered their major effector mechanism. However, we here demonstrate that a major part of central and effector memory CD8+ T cells expresses CD40L, one key molecule for CD4+ T-cell-mediated help. CD40L+ CD8+ T cells are detectable among human antigen-specific immune responses, including pathogens such as influenza and yellow fever virus. CD40L+ CD8+ T cells display potent helper functions in vitro and in vivo, such as activation of antigen-presenting cells, and exhibit a cytokine expression signature similar to CD4+ T cells and unrelated to cytotoxic CD8+ T cells. The broad occurrence of CD40L+ CD8+ T cells in cellular immunity implicates that helper functions are not only executed by major histocompatibility complex (MHC) class ll-restricted CD4+ helper T cells but are also a common feature of MHC class l-restricted CD8+ T cell responses. Due to their versatile functional capacities, human CD40L+ CD8+ T cells are promising candidate cells for immune therapies, particularly when CD4+ T-cell help or pathogen-associated molecular pattern signals are limited. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
14. Comparative Analysis of Immune Responses Induced by Vaccination With SIV Antigens by Recombinant Ad5 Vector or Plasmid DNA in Rhesus Macaques.
- Author
-
Hirao, Lauren A., Ling Wu, Satishchandran, Abhishek, Khan, Amir S., Draghia-Akli, Ruxandra, Finnefrock, Adam C., Bett, Andrew J., Betts, Michael R., Casimiro, Danilo R., Sardesai, Niranjan Y., Kim, J. Joseph, Shiver, John W., and Weiner, David B.
- Subjects
- *
VACCINATION , *IMMUNE response , *DNA vaccines , *ELECTROPORATION , *MACAQUES , *ADENOVIRUS diseases , *SWINE influenza , *THERAPEUTICS - Abstract
DNA vaccines have undergone important enhancements in their design, formulation, and delivery process. Past literature supports that DNA vaccines are not as immunogenic in nonhuman primates as live vector systems. The most potent recombinant vector system for induction of cellular immune responses in macaques and humans is adenovirus serotype 5 (Ad5), an important benchmark for new vaccine development. Here, we performed a head-to-head evaluation of the Merck Ad5 SIV vaccine and an optimized electroporation (EP) delivered SIV DNA vaccine in macaques. Animals receiving the Ad5 vaccine were immunized three times, whereas the DNA-vaccinated animals were immunized up to four times based on optimized protocols. We observed significant differences in the quantity of IFNγ responses by enzyme-linked immunosorbent spot (ELISpot), greater proliferative capacity of CD8+ T cells, and increased polyfunctionality of both CD4+ and CD8+ T cells in the DNA-vaccinated group. Importantly, Ad5 immunizations failed to boost following the first immunization, whereas DNA responses were continually boosted with all four immunizations demonstrating a major advantage of these improved DNA vaccines. These optimized DNA vaccines induce very different immune phenotypes than traditional Ad5 vaccines, suggesting that they could play an important role in vaccine research and development. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.